Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

被引：124

作者：

Sattui, Sebastian Eduardo ^{[1
]}

Liew, Jean W. ^{[2
]}

Kennedy, Kevin ^{[3
]}

Sirotich, Emily ^{[4
]}

Putman, Michael ^{[5
]}

Moni, Tarin T. ^{[6
]}

Akpabio, Akpabio ^{[7
]}

Alpizar-Rodriguez, Deshire ^{[8
]}

Berenbaum, Francis ^{[9
]}

Bulina, Inita ^{[10
]}

Conway, Richard ^{[11
]}

Singh, Aman Dev ^{[12
]}

Duff, Eimear ^{[13
]}

Durrant, Karen L. ^{[14
]}

Gheita, Tamer A. ^{[15
]}

Hill, Catherine L. ^{[16
,17
]}

Howard, Richard A. ^{[18
]}

Hoyer, Bimba F. ^{[19
]}

Hsieh, Evelyn ^{[20
,21
]}

El Kibbi, Lina ^{[22
]}

Kilian, Adam ^{[23
]}

Kim, Alfred Hyoungju ^{[24
]}

Liew, David F. L. ^{[25
,26
]}

Lo, Chieh ^{[27
]}

Miller, Bruce ^{[28
]}

Mingolla, Serena ^{[29
]}

Nudel, Michal ^{[30
]}

Palmerlee, Candace A. ^{[31
]}

Singh, Jasvinder A. ^{[32
,33
]}

Singh, Namrata ^{[34
]}

Ugarte-Gil, Manuel Francisco ^{[35
,36
]}

Wallace, John ^{[37
]}

Young, Kristen J. ^{[38
]}

Bhana, Suleman ^{[39
]}

Costello, Wendy ^{[40
]}

Grainger, Rebecca ^{[41
]}

Machado, Pedro M. ^{[42
,43
]}

Robinson, Philip C. ^{[44
,45
]}

Sufka, Paul ^{[46
]}

Wallace, Zachary S. ^{[47
,48
]}

Yazdany, Jinoos ^{[49
]}

Harrison, Carly ^{[50
]}

Larche, Maggie ^{[51
]}

Levine, Mitchell ^{[52
]}

Foster, Gary ^{[53
]}

Thabane, Lehana ^{[52
]}

Rider, Lisa G. ^{[54
]}

Hausmann, Jonathan S. ^{[48
,55
,56
]}

Simard, Julia F. ^{[57
,58
]}

Sparks, Jeffrey A. ^{[48
,59
]}

机构：

[1] Hosp Special Surg, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA

[2] Boston Univ, Sect Rheumatol, Sch Med, Boston, MA USA

[3] McMaster Univ, Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada

[4] McMaster Univ, Med, Hamilton, ON, Canada

[5] Med Coll Wisconsin, Dept Med, Milwaukee, WI USA

[6] McMaster Univ, Dept Biochem & Biomed Sci, Fac Sci, Hamilton, ON, Canada

[7] Sheffield Teaching Hosp NHS Fdn Trust, Rheumatol, Sheffield, England

[8] Mexican Coll Rheumatol, Res Unit, Mexico City, DF, Mexico

[9] Sorbonne Univ, Rheumatol, Paris, France

[10] Paul Stradins Clin Univ Hosp, Rheumatol Ctr, Dept Internal Dis, Riga, Latvia

[11] St James Hosp, Rheumatol, Dublin, Ireland

[12] GMC, Community Med, Patiala, Punjab, India

[13] St James Hosp, Dept Rheumatol, Dublin, Ireland

[14] Autoinflammatory Alliance, San Francisco, CA USA

[15] Cairo Univ, Fac Med Rheumatol & Clin Immunol, Cairo, Egypt

[16] Queen Elizabeth Hosp, Rheumatol Dept, Adelaide, SA, Australia

[17] Univ Adelaide, Dept Med, Adelaide, SA, Australia

[18] Spondylitis Assoc Amer, Van Nuys, CA USA

[19] Univ Hosp Schleswig, Med Dept 1, Dept Rheumatol & Clin Immunol, Holstein Campus Kiel, Kiel, Schleswig Holst, Germany

[20] Yale Sch Med, Sect Rheumatol Allergy & Immunol, New Haven, CT USA

[21] VA Connecticut Healthcare System, Sect Rheumatol, West Haven Campus, West Haven, CT USA

[22] Specialized Med Ctr Hosp, Rheumatology, Riyadh, Saudi Arabia

[23] St Louis Univ, Dept Internal Med, Div Rheumatol, St Louis, MO USA

[24] Washington Univ, Med Rheumatol, St Louis Sch Med, St Louis, MO USA

[25] Austin Hlth, Rheumatol, Heidelberg, Vic, Australia

[26] Austin Hlth, Clin Pharmacol & Therapeut, Heidelberg, Vic, Australia

[27] I Shou Univ, Coll Med, Yanchau Sheng, Taiwan

[28] Univ Calif San Diego, Med, La Jolla, CA USA

[29] Italian Natl Patient Assoc Rehumatoid & Rare Dis, Rome, Italy

[30] Israeli Assoc RMD Patients Mifrakim Tzeirim, Haifa, Israel

[31] Relapsing Polychondritis Fdn, Int Relapsing Polychondritis Res Network, Walnut Creek, CA USA

[32] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA

[33] Birmingham Vet Affairs Med Ctr, Med Serv, Birmingham, AL USA

[34] Univ Washington, Div Rheumatol, Med, Seattle, WA USA

[35] Univ Cientif Sur, Dept Rheumatol, Lima, Peru

[36] Univ Cientif Sur, Lima, Peru

[37] Autoinflammatory UK, Edinburgh, Midlothian, Scotland

[38] Univ Texas SouthWestern, Div Rheumatol, Sch Med, Dallas, TX USA

[39] Crystal Run Healthcare, Middletown, NY USA

[40] Irish Childrens Arthrit Network iCAN, Tipperary, Ireland

[41] Malaghan Inst Med Res, Dept Med, Wellington, New Zealand

[42] UCL, MRC Ctr Neuromuscular Dis, London, England

[43] UCL, Rheumatol, Ctr Rheumatol, London, England

[44] Univ Queensland, Fac Med, Herston, Qld, Australia

[45] Metro North Hosp & Hlth Serv, Royal Brisbane & Womans Hosp Hlth Serv Dist, Herston, Qld, Australia

[46] Healthpartners, St Paul, MN USA

[47] Massachusetts Gen Hosp, Clin Epidemiol Program & Rheumatol Unit, Div Rheumatol Allergy & Immunol, Boston, MA USA

[48] Harvard Med Sch, Dept Med, Boston, MA 02115 USA

[49] Univ Calif San Francisco, Med Rheumatol, San Francisco, CA USA

[50] LupusChat, New York, NY USA

来源：

RMD OPEN | 2021年 / 7卷 / 03期

基金：

美国国家卫生研究院;

关键词：

COVID-19; vaccination; autoimmune diseases; INFLUENZA VACCINE; ARTHRITIS; REASONS; SAFETY;

D O I：

10.1136/rmdopen-2021-001814

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background We describe the early experiences of adults with systemic rheumatic disease who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an online, international survey of adults with systemic rheumatic disease who received COVID-19 vaccination. We collected patient-reported data on clinician communication, beliefs and intent about discontinuing disease-modifying antirheumatic drugs (DMARDs) around the time of vaccination, and patient-reported adverse events after vaccination. Results We analysed 2860 adults with systemic rheumatic diseases who received COVID-19 vaccination (mean age 55.3 years, 86.7% female, 86.3% white). Types of COVID-19 vaccines were Pfizer-BioNTech (53.2%), Oxford/AstraZeneca (22.6%), Moderna (21.3%), Janssen/Johnson & Johnson (1.7%) and others (1.2%). The most common rheumatic disease was rheumatoid arthritis (42.3%), and 81.2% of respondents were on a DMARD. The majority (81.9%) reported communicating with clinicians about vaccination. Most (66.9%) were willing to temporarily discontinue DMARDs to improve vaccine efficacy, although many (44.3%) were concerned about rheumatic disease flares. After vaccination, the most reported patient-reported adverse events were fatigue/somnolence (33.4%), headache (27.7%), muscle/joint pains (22.8%) and fever/chills (19.9%). Rheumatic disease flares that required medication changes occurred in 4.6%. Conclusion Among adults with systemic rheumatic disease who received COVID-19 vaccination, patient-reported adverse events were typical of those reported in the general population. Most patients were willing to temporarily discontinue DMARDs to improve vaccine efficacy. The relatively low frequency of rheumatic disease flare requiring medications was reassuring.

引用

页数：10

共 50 条

[41] The COVID-19 vaccine: Attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases
Chen, Jiali
Cai, Wenxin
Liu, Tian
Zhou, Yunshan
Jin, Yuebo
Yang, Yue
Chen, Shi
Tang, Kun
Li, Chun
[J]. RHEUMATOLOGY & AUTOIMMUNITY, 2022, 2 (02): : 82 - 91
[42] COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry
Abutiban, Fatemah
Saleh, Khulood
Hayat, Sawsan
Tarakmah, Hoda
Al-Herz, Adeeba
Ghanem, Aqeel
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (07) : 743 - 754
[43] The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
Philip C. Robinson
Jinoos Yazdany
[J]. Nature Reviews Rheumatology, 2020, 16 : 293 - 294
[44] Interest in Global COVID-19 Vaccine Alliance Grows
Kuehn, Bridget M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11): : 1025 - 1025
[45] Use of tofacitinib in the context of COVID-19 vaccination: comment on the American College of Rheumatology clinical guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases
Mortezavi, Mahta
Menon, Sujatha
Lee, Kristen
Rivas, Jose
[J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (09) : 1768 - 1769
[46] The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
Robinson, Philip C.
Yazdany, Jinoos
[J]. NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (06) : 293 - 294
[47] Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry
Izadi, Zara
Gianfrancesco, Milena A.
Aguirre, Alfredo
Strangfeld, Anja
Mateus, Elsa F.
Hyrich, Kimme L.
Gossec, Laure
Carmona, Loreto
Lawson-Tovey, Saskia
Kearsley-Fleet, Lianne
Schaefer, Martin
Seet, Andrea M.
Schmajuk, Gabriela
Jacobsohn, Lindsay
Katz, Patricia
Rush, Stephanie
Al-Emadi, Samar
Sparks, Jeffrey A.
Hsu, Tiffany Y-T
Patel, Naomi J.
Wise, Leanna
Gilbert, Emily
Duarte-Garcia, Ali
Valenzuela-Almada, Maria O.
Ugarte-Gil, Manuel F.
Ribeiro, Sandra Lucia Euzebio
Marinho, Adriana de Oliveira
Valadares, Lilian David de Azevedo
Di Giuseppe, Daniela
Hasseli, Rebecca
Richter, Jutta G.
Pfeil, Alexander
Schmeiser, Tim
Isnardi, Carolina A.
Torres, Alvaro A. Reyes
Alle, Gelsomina
Saurit, Veronica
Zanetti, Anna
Carrara, Greta
Labreuche, Julien
Barnetche, Thomas
Herasse, Muriel
Plassart, Samira
Santos, Maria Jose
Rodrigues, Ana Maria
Robinson, Philip C.
Machado, Pedro M.
Sirotich, Emily
Liew, Jean W.
Hausmann, Jonathan S.
[J]. ACR OPEN RHEUMATOLOGY, 2022, 4 (10) : 872 - 882
[48] Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry
Yazdany, Jinoos
Ware, Anna
Wallace, Zachary S.
Bhana, Suleman
Grainger, Rebecca
Hachulla, Eric
Richez, Christophe
Cacoub, Patrice
Hausmann, Jonathan S.
Liew, Jean W.
Sirotich, Emily
Jacobsohn, Lindsay
Strangfeld, Anja
Mateus, Elsa F.
Hyrich, Kimme L.
Gossec, Laure
Carmona, Loreto
Lawson-Tovey, Saskia
Kearsley-Fleet, Lianne
Schaefer, Martin
Ribeiro, Sandra Lucia Euzebio
Al-Emadi, Samar
Hasseli, Rebecca
Mueller-Ladner, Ulf
Specker, Christof
Schulze-Koops, Hendrik
Bernardes, Miguel
Fraga, Vanessa Machado
Rodrigues, Ana Maria
Sparks, Jeffrey A.
Ljung, Lotta
Di Giuseppe, Daniela
Tidblad, Liselotte
Wise, Leanna
Duarte-Garcia, Ali
Ugarte-Gil, Manuel F.
Colunga-Pedraza, Iris Jazmin
Martinez-Martinez, Marco Ulises
Alpizar-Rodriguez, Deshire
Xavier, Ricardo Machado
Isnardi, Carolina A.
Pera, Mariana
Pons-Estel, Guillermo
Izadi, Zara
Gianfrancesco, Milena A.
Carrara, Greta
Scire, Carlo Alberto
Zanetti, Anna
Machado, Pedro M.
[J]. ARTHRITIS CARE & RESEARCH, 2024, 76 (02) : 274 - 287
[49] Survey data on perceived COVID-19 risk, COVID-19 vaccine perception, and COVID-19 vaccination intention among Vietnamese
Nguyen, Phi-Hung
Van Nguyen, Duy
[J]. DATA IN BRIEF, 2022, 40
[50] COVID-19 IN ITALIAN PATIENTS WITH RHEUMATIC AUTOIMMUNE SYSTEMIC DISEASES: RESULTS OF A NATIONWIDE SURVEY STUDY
Ferri, C.
Giuggioli, D.
Raimondo, V.
Dagna, L.
Riccieri, V.
Zanatta, E.
Guiducci, S.
Tavoni, A.
Foti, R.
Cuomo, G.
De Angelis, R.
Cozzi, F.
Murdaca, G.
Cavazzana, I.
Romeo, N.
Codullo, V.
Ingegnoli, F.
Pellegrini, R.
Varcasia, G.
Della Rossa, A.
De Santis, M.
Abignano, G.
Colaci, M.
Caminiti, M.
L'andolina, M.
Lubrano, E.
Spinella, A.
Lumetti, F.
De Luca, G.
Randone, S. Bellando
Visalli, E.
Bilia, S.
Masini, F.
Pellegrino, G.
Pigatto, E.
Generali, E.
Franceschini, F.
Mariano, G. Pagano
Barsotti, S.
Pettiti, G.
Zanframundo, G.
Brittelli, R.
Aiello, V.
Scorpiniti, D.
Ferrari, T.
Caminiti, R.
Campochiaro, C.
Gigliotti, P.
Cecchetti, R.
Olivo, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 906 - 907

← 1 2 3 4 5 →